Viewing data from:

FLURBIPROFEN

ANDA

FLURBIPROFEN | A074431 | NEW HEIGHTSRX LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$3.32

per ea

Lowest NADAC/Unit

$3.32

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
71085008230LURBIRO 100 MG TABLET	$3.32	EA	Generic	—	2026-06-17
64950021810FLURBIPROFEN 100 MG TABLET	$3.32	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

PHARMARON MANUFACTURING SERVICES UK LTDFLURBIPROFEN

DMF 24351975

FDC LTDFLURBIPROFEN USP

DMF 82191989

WR GRACE AND COFLURBIPROFEN USP & BP

DMF 119021996

RA CHEM PHARMA LTDFLURBIPROFEN USP

DMF 339952019

SUZHOU RYWAY BIOTECH CO LTDFLURBIPROFEN

DMF 410682024

KV PHARMACEUTICAL COInactiveFLURBIPROFEN 200MG CAPS

DMF 47601982

FOREST LABORATORIES INCInactiveFLURBIPROFEN 100 MG C.R.TABS (IN SYNCHRON VEHICLE

DMF 51851983

FOREST LABORATORIES INCInactiveFLURBIPROFEN 200 mg C.R. TABS (IN SYNCHRON VEHICLE

DMF 51921983

ERREGIERRE SPAInactiveFLURBIPROFEN

DMF 96411992

WYCKOFF CHEMICAL CO INCInactiveFLURBIPROFEN

DMF 98401992

VASUDHA PHARMA CHEM LTDInactiveFLURBIPROFEN USP

DMF 328762018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 31, 1995

No patent or exclusivity listings for this strength.